FDA Inspection
Catalent Belgium SACatalent Belgium SA – FDA Inspection, Feb 15, 2019
Record Details
This FDA Inspection record concerns Catalent Belgium SA, with an inspection on February 15, 2019, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · e06b9297-26d5-4f83-8a2e-a68bd54aee5c
Inspection Facts
- Inspection number
- 1082390
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Catalent Belgium SA
13| Date | Classification | Office | Project area |
|---|---|---|---|
| July 12, 2024 | Not classified | Office of Inspections and Investigations | |
| April 7, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 19, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 22, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 19, 2019 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for Catalent Belgium SA
- FDA Inspection 1273463 - 2024-07-12
- FDA Inspection 1246550 - 2023-04-07
- FDA Inspection 1177876 - 2022-08-19
- FDA Inspection 1136201 - 2020-01-22
- FDA Inspection 1093395 - 2019-06-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.